We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TF
201
Tompkins Financial
New York
$545K +$587K +11,521 New
V
202
Veritable
Delaware
$539K +$580K +11,390 New
IPC
203
Independent Portfolio Consultants
Florida
$521K +$561K +11,023 New
WA
204
WFG Advisors
Texas
$510K +$549K +10,778 New
Canada Pension Plan Investment Board
205
Canada Pension Plan Investment Board
Ontario, Canada
$480K +$517K +10,146 New
LCM
206
LVM Capital Management
Michigan
$473K +$509K +10,000 New
TSW
207
Thompson Siegel & Walmsley
Virginia
$473K +$509K +10,005 New
HFS
208
HL Financial Services
Kentucky
$469K +$505K +9,921 New
TCOTO
209
Trust Company of the Ozarks
Missouri
$467K +$504K +9,891 New
TD Asset Management
210
TD Asset Management
Ontario, Canada
$446K +$480K +9,424 New
LWI
211
Long Wharf Investors
Massachusetts
$441K +$475K +9,320 New
BNP Paribas Financial Markets
212
BNP Paribas Financial Markets
France
$440K +$474K +9,302 New
Envestnet Asset Management
213
Envestnet Asset Management
Illinois
$416K +$448K +8,797 New
FCCM
214
First City Capital Management
Georgia
$414K +$446K +8,750 New
WSA
215
Willow Street Advisors
Florida
$412K +$443K +8,700 New
DC
216
Davenport & Co
Virginia
$410K +$442K +8,673 New
WTC
217
WhitTier Trust Company
Nevada
$405K +$436K +8,560 New
KFS
218
KMS Financial Services
Washington
$394K +$424K +8,321 New
LNWWM
219
Laird Norton Wetherby Wealth Management
California
$388K +$418K +8,205 New
CRC
220
Curi RMB Capital
Illinois
$380K +$408K +8,015 New
HNB
221
Huntington National Bank
Ohio
$378K +$407K +8,000 New
MM
222
Midas Management
New York
$378K +$407K +8,000 New
MG
223
MDE Group
New Jersey
$368K +$396K +7,785 New
ICAS
224
Investors Capital Advisory Services
Massachusetts
$366K +$394K +7,744 New
AP
225
Advisor Partners
California
$361K +$388K +7,629 New
7 8
9
10 11

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.